Chinese Factory Linked to Drug Under Inquiry in U.S.
After the Trader Joe’s and pet food cases, now the spotlight is on Chinese drugs, from The New York Times:
A Chinese factory that has not been inspected by the Food and Drug Administration is the source for the active ingredient of a critical blood-thinning drug whose production was suspended this week after 350 patients reported ill effects from it.
At least four people died after being given the drug, heparin.
An F.D.A. spokeswoman, Heidi Robello, said Wednesday that the agency was making plans to inspect the Chinese factory as well as a finishing plant in New Jersey “as soon as possible.”
See also “China scrutinized in blood thinner problems” from the Los Angeles Times.
Origin: Gardiner Harris, New York Times
POSTED COMMENTS: 2 Responses
Very different spin from the CNN article, which tends to place the blame not on the Chinese factory, but the FDA for not doing its own due diligence. (the article there says that the FDA didnt because of human error and IT issues)
I apologize, it was a CNN Money article. (I posted parts of both on my blog at http://www.chinalawandbusiness.com)